Artificial Intelligence Evaluation of Fascial Plane Block Quality and Postoperative Pain in Cardiac Surgery (FASCAI)

May 6, 2026 updated by: Anıl Onur, Bursa Yuksek Ihtisas Training and Research Hospital

AI-Assisted Evaluation of Anatomical Success of Fascial Plane Blocks Applied in Open Heart Surgery and Investigation of Its Relationship With Postoperative Pain Scores: A Prospective Observational Study

Postoperative pain is a common and significant problem following open heart surgery. Fascial plane blocks (FPBs) such as Serratus Anterior Plane Block (SAPB), Pectoral Nerve Blocks (PECS), and Pecto-Intercostal Fascial Block (PIFB) are increasingly used as part of multimodal analgesia in cardiac surgery. However, objective assessment of block quality and its relationship with clinical outcomes remains limited in the literature.

This prospective observational study aims to evaluate the anatomical success of ultrasound-guided fascial plane blocks applied in elective open heart surgery (median sternotomy) using two simultaneous methods: a trained artificial intelligence (AI) model and a blinded expert anesthesiologist. Block images will be recorded in DICOM format and scored on a 3-point scale (1: incorrect anatomical placement, 2: patchy spread, 3: ideal anatomical placement). The relationship between anatomical block success scores and postoperative pain (NRS at 0, 6, 12, 24, and 48 hours), total analgesic consumption, and clinical outcomes will be investigated. Agreement between AI and blinded anesthesiologist assessments will also be analyzed.

Study Overview

Detailed Description

Patients scheduled for elective open heart surgery via median sternotomy will be enrolled after obtaining written informed consent, including separate consent for AI-based image analysis. All patients will undergo routine anesthetic management including BIS monitoring, intra-arterial cannulation, standard anesthesia induction, orotracheal intubation, and central venous catheterization.

Fascial Plane Block Application:

Following general anesthesia induction, fascial plane blocks routinely performed in our clinic will be applied by a blinded anesthesiologist using a high-frequency linear ultrasound probe (10-15 MHz, G-brand). The blocks applied include SAPB + PIFB combination or bilateral parasternal (PIFB) block, depending on the surgical decision. All blocks will be performed using 0.25% bupivacaine (total bilaterally 30 mL) under sterile conditions with an in-plane technique.

Image Recording Protocol:

Block images will be recorded in a standardized manner including: pre-block anatomical scanning, video recording during needle placement, local anesthetic spread images, and post-injection final images. All images will be recorded in DICOM format (minimum 1920x1080 resolution) with standardized depth, gain, and focus settings. Patient identifiers will be anonymized.

AI Model Development:

A Convolutional Neural Network (CNN)-based model (U-Net or ResNet architecture) will be trained using expert-labeled ultrasound images from NYSORA references. The dataset will be divided into 70% training, 20% validation, and 10% test sets using data augmentation and cross-validation techniques. The model will evaluate anatomical landmark recognition accuracy, local anesthetic spread segmentation (Dice coefficient), and similarity to ideal block (0-100 score).

Block Quality Scoring:

Recorded ultrasound images will be independently scored by both the trained AI model and a blinded expert anesthesiologist using a 3-point scale:

  1. Anatomically incorrect block
  2. Anatomically patchy block
  3. Anatomically ideal block

Postoperative Follow-up:

Patients will be followed postoperatively with NRS pain scores (at rest and with coughing) at 0, 6, 12, 24. Additional parameters recorded include total analgesic consumption, side effects (nausea, vomiting, pruritus), complications, mobilization time, ICU stay, and hospital length of stay.

Statistical Analysis:

Correlation between AI scores and postoperative pain scores will be assessed using Pearson or Spearman correlation. Factors affecting pain scores will be evaluated by multiple linear regression. Differences between block types will be analyzed using ANOVA or Kruskal-Wallis test. Agreement between AI and blinded anesthesiologist assessments will be analyzed using Cohen's kappa coefficient.

Sample Size:

Based on pilot study data, 120 patients are planned with 95% power.

Study Type

Observational

Enrollment (Actual)

120

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Yıldırım
      • Bursa, Yıldırım, Turkey (Türkiye), 16600
        • University of Health Sciences Bursa Yuksek Ihtisas Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

Patients scheduled for elective open heart surgery via median sternotomy at the University of Health Sciences Bursa Yüksek Ihtisas Training and Research Hospital, Department of Anesthesiology and Reanimation. All eligible patients who meet the inclusion criteria and provide written informed consent, including separate consent for AI-based ultrasound image analysis, will be enrolled consecutively.

Description

Inclusion Criteria:

  • Age between 18-80 years
  • Patients scheduled for elective cardiac surgery (CABG, valve surgery, combined procedures)
  • Patients undergoing median sternotomy
  • ASA physical status II-III
  • Patients capable of providing informed consent, including separate consent for AI-based image analysis

Exclusion Criteria:

  • Emergency surgery
  • Redo sternotomy
  • Allergy to local anesthetics
  • Coagulopathy (INR >1.5, platelet count <80,000/mm³)
  • Infection at the block application site
  • Chronic opioid use (>3 months)
  • Cognitive dysfunction
  • Pregnancy
  • ASA physical status IV and above
  • Minimally invasive surgery performed via thoracotomy

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Fascial Plane Block Group
Patients scheduled for elective open heart surgery via median sternotomy who receive routine ultrasound-guided fascial plane blocks (bilateral parasternal PIFB block) under general anesthesia. Block images are independently scored by a trained AI model and a blinded expert anesthesiologist. Patients are followed postoperatively for pain scores, analgesic consumption, and clinical outcomes.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Postoperative Pain Score
Time Frame: 48 hours postoperatively
Postoperative pain assessed using the Numerical Rating Scale (NRS) at rest and with coughing at 0, 6, 12, 24 hours after surgery. NRS ranges from 0 (no pain) to 10 (worst imaginable pain).
48 hours postoperatively

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Agreement Between AI and Blinded Anesthesiologist Block Quality Scores
Time Frame: Intraoperative
Comparison of fascial plane block anatomical success scores assigned by the trained AI model and the blinded expert anesthesiologist using a 3-point scale (1: incorrect, 2: patchy, 3: ideal). Agreement assessed by Cohen's kappa coefficient.
Intraoperative
Total Analgesic Consumption
Time Frame: 24 hours postoperatively
Total amount and type of analgesic agents consumed during the postoperative 24-hour period.
24 hours postoperatively
ICU Length of Stay
Time Frame: Through ICU discharge, approximately 1-7 days
Duration of stay in the intensive care unit following open heart surgery.
Through ICU discharge, approximately 1-7 days
Hospital Length of Stay
Time Frame: Through hospital discharge, approximately 5-10 days
Total duration of hospital stay following open heart surgery.
Through hospital discharge, approximately 5-10 days
Postoperative Complications
Time Frame: 48 hours postoperatively
Incidence of postoperative complications including nausea, vomiting, pruritus, and other adverse events related to fascial plane blocks or analgesic use.
48 hours postoperatively
Time to Mobilization
Time Frame: Through hospital discharge, approximately 5-14 days
Time from end of surgery to first patient mobilization.
Through hospital discharge, approximately 5-14 days

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2025

Primary Completion (Actual)

May 1, 2026

Study Completion (Actual)

May 1, 2026

Study Registration Dates

First Submitted

May 6, 2026

First Submitted That Met QC Criteria

May 6, 2026

First Posted (Actual)

May 12, 2026

Study Record Updates

Last Update Posted (Actual)

May 12, 2026

Last Update Submitted That Met QC Criteria

May 6, 2026

Last Verified

May 1, 2026

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

Individual participant data will not be shared due to patient privacy and confidentiality concerns, as the study involves anonymized ultrasound images and clinical data collected at a single center. Data may be made available upon reasonable request to the principal investigator.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Pain, Postoperative

Subscribe